Olga Starobová – Medical Director, Medical Management and Scientific Services, Syneos Health Czech Republic

In the future, I would like to see more gene therapies being conducted in the country. This is the future of research and treatment
In the future, I would like to see more gene therapies being conducted in the country. This is the future of research and treatment
Out of 280 foreign companies with products on the Moroccan market, 260 market their products in partnership with AMIP members
The current form of clawback is profoundly incorrect, as it is damaging to patients and the Romanian drug industry. Furthermore, it endangers the sustainability and existence…
Sanofi is in the privileged position of having one of the most diversified portfolios in the market
Our vision was to create a regional platform ready to license, market and commercialize innovation from companies that did not want to be in the region…
The only way to make a difference is through listening and partnerships. Takeda’s DNA is very much about perseverance
Thanks to our strong clinical network, a vast majority of our early discovery that happens across the globe is sent through Belgium
My main priority is to merge these unique sets of experiences from different countries and bring everyone together on the same page, so that every problem…
What sets Arega apart from the average distributor in the Belgian market is the extensive industry experience that we have
As part of the AIFP, Sanofi is very much involved in trying to shape the environment in a way that provides a better frame and visibility…
Companies choose to invest in an environment that can ensure stability and predictability and that provides fair public policy
Along with the Netherlands, Luxembourg, Austria, and Ireland, we collaborate in the four topics of health technology assessment, information exchange, joint negotiations with the industry, and…
See our Cookie Privacy Policy Here